A synthetic cannabinoid pharmaceutical called Rimonabant was briefly approved in Europe as an anti-obesity drug. Rimonabant inhibits the CB1
In spite of the munchies, using THC-rich cannabis is associated with lower weight and a smaller risk for Type II diabetes. This is well substantiated by human epidemiology and research.
During the first week of July 2018, five-hundred-and-thirty-five delegates from five continents met at the University of Leiden in the Netherlands for the 28th annual symposium of the International Cannabinoid Research Society (ICRS). The four-day conference showcased recent scientific discoveries about
Food is medicine. This delicious pumpkin curry recipe by Nature Going Smart is full of ingredients with powerful healing properties.
could be vital in understanding diet, digestion, and energy metabolism. It could be the key in understanding today’s obesity epidemic. What dietary changes can we make to support our endocannabinoid systems?